 |
PDBsum entry 6d2m
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.4.2.1.1
- carbonic anhydrase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
hydrogencarbonate + H+ = CO2 + H2O
|
 |
 |
 |
 |
 |
hydrogencarbonate
|
+
|
H(+)
|
=
|
CO2
|
+
|
H2O
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
ChemMedChem
13:2024-2029
(2018)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural Mapping of Anion Inhibitors to β-Carbonic Anhydrase psCA3 from Pseudomonas aeruginosa.
|
|
A.B.Murray,
M.Aggarwal,
M.Pinard,
D.Vullo,
M.Patrauchan,
C.T.Supuran,
R.McKenna.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Pseudomonas aeruginosa is a Gram-negative facultative anaerobe belonging to the
Pseudomonadaceae family. It is a multidrug-resistant opportunistic human
pathogen, a common cause of life-threatening nosocomial infections, and a key
bacterial agent in cystic fibrosis and endocarditis. The bacterium exhibits
intrinsic resistance to most antibacterial agents, including aminoglycosides and
quinolones. Hence, the identification of new drug targets for P. aeruginosa is
ongoing. PsCA3 is a β-class carbonic anhydrase (β-CA) that catalyzes the
reversible hydration of carbon dioxide to bicarbonate and represents a new class
of antimicrobial target. Previously, inhibitor screening studies of psCA3 have
shown that a series of small anions including sulfamide (SFN), imidazole (IMD),
and 4-methylimidazole (4MI), and thiocyanate (SCN) inhibit the enzyme with
efficiencies in the micro- to millimolar range. Herein the X-ray crystal
structures of these inhibitors in complex with psCA3 are presented and compared
with human CA II. This structural survey into the binding modes of small
anions forms the foundation for the development of inhibitors against β-CAs and
more selective inhibitors against P. aeruginosa.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |